$NTII NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEUROBIOLOGICAL TECHNOLOGIES INC /CA/.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in NEUROBIOLOGICAL TECHNOLOGIES INC /CA/. Find out how many shares they currently own, their value and whether they buy or sell their shares.
NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| BVF PARTNERS L P/IL | 10% Owner | 331,998 | 6,640 | Oct 23 2009 | |||
| CALLAWAY ENOCH | Director | 100,538 | 2,011 | Mar 19 2004 | |||
| CALLAWAY ENOCH | Director | 0 | 0 | Nov 24 2004 | |||
| CALLAWAY ENOCH | Director | 0 | 0 | Feb 14 2008 | |||
| CAPE RONALD | Director | 0 | 0 | Nov 20 2007 | |||
| CARLSON CRAIG W | VP and Chief Financial Officer | 1,000 | 20 | Nov 01 2007 | |||
| CARR LISA U MD PHD | Sr. Vice President | 0 | 0 | Sep 27 2004 | |||
| CARR LISA U MD PHD | Sr. Vice President | 94,034 | 1,881 | Mar 02 2006 | |||
| COHEN ABRAHAM E | Director | 525,747 | 10,515 | Dec 14 2004 | |||
| COHEN ABRAHAM E | Director | 0 | 0 | Dec 02 2004 | |||
| COHEN ABRAHAM E | Director | 133,707 | 2,674 | Nov 09 2009 | |||
| DONDERO JAMES D | 10% Owner | 4,737,479 | 94,750 | Nov 04 2008 | |||
| ELIOT THEODORE | Director | 17,322 | 346 | Nov 24 2004 | |||
| ELIOT THEODORE | Director | 18,322 | 366 | Oct 28 2005 | |||
| ELIOT THEODORE | Director | 17,617 | 352 | Oct 29 2009 | |||
| Firefly Value Partners, LP | 10% Owner | 1,994,798 | 39,896 | Jun 09 2010 | |||
| Fletcher William A | Acting Chief Executive Officer | 83,600 | 1,672 | Oct 29 2009 | |||
| FREIMAN PAUL E | 14,920 | 298 | Feb 12 2009 | ||||
| FREIMAN PAUL E | President and CEO | 0 | 0 | Sep 27 2004 | |||
| FREIMAN PAUL E | President and CEO | 17,386 | 348 | Jun 03 2008 | |||
| HIGHLAND CAPITAL MANAGEMENT LP | 10% Owner | 4,951,154 | 99,023 | Jan 03 2008 | |||
| J P MORGAN CHASE & CO | 10% Owner | 0 | 0 | Nov 18 2008 | |||
| KASPER F VAN | Director | 0 | 0 | Dec 02 2004 | |||
| KASPER F VAN | Director | 140,000 | 2,800 | Apr 15 2004 | |||
| KASPER F VAN | Director | 58,600 | 1,172 | Oct 29 2009 | |||
| Levy David E | VP of Clinical Development | 13,115 | 262 | Jun 03 2008 | |||
| LOAR MATTHEW M | VP and Chief Financial Officer | 25,000 | 500 | Oct 23 2008 | |||
| PETTI STEPHEN J | VP of Product Development | 2,030,818 | 40,616 | Mar 07 2006 | |||
| SOFAER ABRAHAM D | Director | 417,927 | 8,359 | Mar 12 2004 | |||
| SOFAER ABRAHAM D | Director | 443,782 | 8,876 | Dec 06 2004 | |||
| SOFAER ABRAHAM D | Director | 125,931 | 2,519 | Oct 29 2009 | |||
| STUPPIN JOHN B | Director | 710,681 | 14,214 | May 27 2005 | |||
| STUPPIN JOHN B | Director | 183,876 | 3,678 | Dec 30 2009 | |||
| Wasiewski Warren W | Vice President, CMO | 10,000 | 200 | Nov 14 2008 | |||
| Wolter Jonathan R | VP and Chief Financial Officer | 0 | 0 | Sep 26 2005 |